As of May 26
| -0.05 / -1.82%|
The 3 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 10.00 and a low estimate of 6.00. The median estimate represents a +122.22% increase from the last price of 2.70.
The current consensus among 4 polled investment analysts is to Buy stock in NovaBay Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.